Latest News
Putting a sustainable spin on laundry, Oxwash, a UK-based startup backed by Twitter co-founder Biz Stone has raised GBP500,000 in equity investment through a public crowdfunder.
The company founded in 2018 by ex-NASA scientist and Forbes Europe’s 30 under 30 alumni, Dr Kyle Grant and Oxford engineer Tom de Wilton, secured GBP250,000 from five angel investors including Magnus Rausing (Tetra Pak), Kal Patel (ex-CEO of Best Buy) and Vala Capital, in addition to a quarter of a million from 318 public Crowdcube investors.
And follows a GBP2.08 million raise in June 2021 from committed investors such as Holly and Sam
KKR is to make an investment in Beacon Pointe, the parent company to Beacon Pointe Advisors. The Beacon Pointe team will continue to own over 50 per cent of the company going forward, while Abry Partners (Abry) will fully exit its investment as a result of the transaction.
KKR’s investment will provide Beacon Pointe with growth capital to support key priorities and continue the Company’s strategy for national expansion through new office openings and acquisitions. Beacon Pointe’s brand, culture and executive leadership team will remain intact, and clients will continue to receive the same level of high-quality, high-touch and high-tech
Marketing and consumer insights platform Prodege has secured a major investment from Great Hill Partners, a private equity firm that invests in high-growth, disruptive companies.
Great Hill’s investment will be used to support the Company’s rapid organic expansion and targeted acquisition strategy. Financial terms of the transaction were not disclosed.
Prodege provides its partners with marketing, data, and analytics solutions that enable leading brands and agencies to gather insights, target their core audiences, acquire new customers, boost engagement, increase revenue, and drive brand loyalty and product adoption. Prodege offers its members cash back and rewards for their everyday online activities
The Global Real Estate Sustainability Benchmark (GRESB) has awarded Beacon Capital Partners an Overall Regional Sector Leader award for its environmental, social, governance, and resilience leadership efforts on behalf of Fund 7.
“GRESB Sector Leaders are the organisations that are setting the pace and driving progress toward a net zero future. We are proud to recognise your determination, achievement, and leadership in creating a more sustainable world,” says Sebastien Roussotte, CEO of GRESB.
Each year, GRESB assesses and benchmarks the ESG performance of assets worldwide, providing clarity and insights to financial markets on complex sustainability topics. GRESB data is used
Adelis Equity Partners Fund III (Adelis III) has held a final close following a short period of fundraising. The Fund, which was significantly oversubscribed, raised EUR855 million from external investors, on top of which Adelis’ employees have committed to invest 9 per cent, or EUR77 million, for a total fund size of EUR932 million.
Investors in Adelis III include leading pension funds, foundations and fund-of-funds from Europe and North America. Investors in Adelis Equity Partners Fund II, all of whom are represented in Adelis III, make up the vast majority of the capital.
Adelis is a growth partner for well-positioned,
Alternative investment platform CAIS has appointed George Davies, PhD, as its new Head of Data. Based in the Company’s New York office, Davies will report to Shane Williams, Chief Technology Officer.
“We are delighted to welcome George to this newly created position,” says Williams. “George’s track record working with data to enhance areas such as risk management, trade modelling, and pricing will complement our efforts to employ CAIS’ own data for trend spotting, creating personalised experiences for advisors, delivering meaningful engagements for managers, and informing business decisions.”
Davies has worked with technology platforms across wealth advisory, asset management, and trading
Cboe Global Markets, a provider of global market infrastructure and tradable products, is to acquire Aequitas Innovations, more commonly known as NEO, a fintech organisation that comprises of a fully registered Tier-1 Canadian securities exchange with a diverse product and services set ranging from corporate listings to cash equity trading.
Ownership of NEO will help allow Cboe to provide a more fulsome Canadian equities offering, operating the NEO Exchange, a national securities exchange with trading, listings and other services, in addition to MATCHNow, the alternative trading system (ATS) acquired by Cboe in 2020. This strengthened offering is expected to drive
Untap, a next generation portfolio management solution for private capital markets to manage investments, strategies, ESG and Value Creation, has been accepted into Newchip’s renowned global accelerator programme.
Designed to provide all the skills and tools seed-stage founders need to rapidly fund, build and scale their companies, past accelerator cohorts averaged more than 17.5 times the average funding amount. The equity-free, fully digital accelerator has helped over 1,000 founders from 35 countries raise over USD300 million in funding.
“Newchip evaluates a vast and diverse number of companies from across the globe, selecting only a small percentage to be part of
Robert Bosch Venture Capital, the corporate venture capital company of the Bosch Group, has completed an investment in Variantyx Inc.
Variantyx and Robert-Bosch Hospital join forces to improve personalised oncology treatment with plans to incorporate the Variantyx solution into the oncology treatment process. Variantyx provides clinicians with advanced diagnostics and personalised treatment recommendations for oncology patients’ based on their unique genetic makeup.
“For several years the Robert-Bosch Hospital, the Robert Bosch Stiftung, and the Bosch Group have been joining forces to fight cancer,” says Dr Ingo Ramesohl, Managing Director of Robert Bosch Venture Capital. “Variantyx’s solution is outstanding. Together, Variantyx
Gentronix, the UK-based contract research organisation (CRO) in the field of genetic toxicology, has raised GBP700,000 in a funding round led by existing investor Mercia to support its continued growth.
The latest round, which includes a number of private investors, follows Gentronix’s recent acquisition of the Big Blue® transgenic mutation assay from Merck KGaA. It will be used to fund the onboarding and delivery of the new service and expand the company’s genetic, skin and ocular toxicology services.
Gentronix provides companies developing new chemical or pharmaceutical products with toxicology tests required by regulators to show that they are safe
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
